Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for attention and executive function deficits in children with neurofibromatosis type 1
ACTRN12611000765921Phase 2Terminated
- Sponsor
- The Children's Hospital at Westmead
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of methylphenidate in neurofibromatosis type 1 (NF1), sponsored by The Children's Hospital at Westmead. Started Jul 2011; status: terminated.
02
Drugs
methylphenidate
03
Conditions
neurofibromatosis type 1 (NF1)
Beyond the preview
Go deeper on ACTRN12611000765921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000765921.